Position in BIIB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,661,285
+$9,299 QoQ
Shares Held
7,689
-14.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#366
of 1,031 holders
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Focus Partners Advisor Solutions, LLC holds $66,251,630 across 13 Drug Manufacturers - General names. BIIB ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,987 | $16,776,428 | |
| 2 | JNJ |
Johnson & Johnson
|
47,169 | $11,979,510 | |
| 3 | MRK |
Merck & Co., Inc.
|
86,089 | $11,062,436 | |
| 4 | ABBV |
AbbVie Inc.
|
39,485 | $9,936,005 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
96,478 | $5,559,062 | |
| 6 | PFE |
Pfizer Inc
|
145,419 | $3,501,689 | |
| 7 | AMGN |
Amgen Inc
|
6,527 | $2,363,557 | |
| 8 | BIIB |
Biogen Inc.
This page
|
7,689 | $1,661,285 |
All Filings in BIIB
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,661,285 | 7,689 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $1,651,986 | 9,011 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $1,320,804 | 7,505 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $1,034,770 | 7,387 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $792,598 | 6,311 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $725,388 | 5,301 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $320,805 | 1,655 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $258,711 | 1,116 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $207,867 | 964 | Shares | Other | 2024-05-15 | |
| 2022-12-31 | $209,628 | 757 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $447,492 | 1,676 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||